What is the long-term trend for Integra LifeSciences's selling general and administrative expense?

Over 4 years (2021 to 2025), Integra LifeSciences's selling general and administrative expense has grown at a 2.4% compound annual growth rate (CAGR), from $637.45M to $699.7M.

Integra LifeSciences IART Selling General And Administrative Expense

Selling General And Administrative Expense at other companies

BeldenBDC

$138.65M+5.4%

Hooker Furnishings CorporationHOFT

$18.47M+4.0%

ROC

Rank One Computing ROC

$2.93M+48.4%

DJT

Trump Media & Technology GroupDJT

$37.94M+50.7%

Proficient Auto Logistics, Inc.PAL

$4.36M+6.3%

Solidion Technology, Inc.STI

$1.46M-18.2%

Segments

By segment

See full

Specialty Surgery$75.98M—

Tissue Reconstruction$40.39M—

Other financials

Income statement

See full

Revenue$418.8M+0.8%

Gross profit$219.7M+5.0%

Operating income$19.3M+104%

Net income$4.5M+101%

EPS (diluted)$0.06+101%

Balance sheet

See full

Cash & equivalents$214.4M-1.6%

Total debt$2.0B+3.2%

Total equity$1.0B+0.5%

Total assets$3.6B-2.8%

Cash flow

See full

Operating cash flow$22.8M+156%

CapEx$12.3M-38.9%

Free cash flow$10.5M+193%

Valuation

See full

Market cap$1.52B+49.2%

Enterprise value$3.27B+20.9%

P/S0.9×+0.3×

Profitability

See full

Gross margin52.5%-0.1pp

Operating margin2.6%+1.3pp

Net margin-0.4%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-0.7%—

Debt / equity1.9×+0.1×

Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Integra LifeSciences’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's selling general and administrative expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's selling general and administrative expense?: Integra LifeSciences (IART) reported selling general and administrative expense of $172.44M in Q2 2026.
How has Integra LifeSciences's selling general and administrative expense changed year-over-year?: Integra LifeSciences's selling general and administrative expense decreased by 4.1% year-over-year, from $179.89M to $172.44M.
What is the long-term trend for Integra LifeSciences's selling general and administrative expense?: Over 4 years (2021 to 2025), Integra LifeSciences's selling general and administrative expense has grown at a 2.4% compound annual growth rate (CAGR), from $637.45M to $699.7M.